Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

HSK 1 – For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese HSK 1 course with a companion app in 21 languagesfree forever.

Arabic, Bengali, Dutch, English, Farsi, French, German, Hindi, Indonesian, Italian, Japanese, Korean, Portuguese, Russian, Spanish, Tagalog, Thai, Turkish, Ukrainian, Urdu, Vietnamese.

By Bernd Sebastian Kamps and Andrea Melis

  Pancreatitis

  Free Subscription


Articles published in Nature

Retrieve available abstracts of 40 articles:
HTML format



Single Articles


    April 2026
  1. ROTH G, Artru P, Bouche O, Williet N, et al
    Netrin1 blockade alleviates resistance to chemotherapy in pancreatic cancer.
    Nature. 2026 Apr 22. doi: 10.1038/s41586-026-10436.
    PubMed     Abstract available


  2. VIALE A, Pettazzoni P, Lyssiotis CA, Ying H, et al
    Author Correction: Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function.
    Nature. 2026 Apr 8. doi: 10.1038/s41586-026-10488.
    PubMed    


    February 2026
  3. LEI J, Yang K, Cao W, Qi S, et al
    Pancreatic-targeted lipid nanoparticles based on organ capsule filtration.
    Nature. 2026 Feb 25. doi: 10.1038/s41586-026-10158.
    PubMed     Abstract available


    December 2025
  4. KING A
    Therapeutic vaccines can challenge pancreatic cancer before it takes hold.
    Nature. 2025;648:S58-S60.
    PubMed    


  5. NUWER R
    The pancreatic cancer models helping to drive innovation in the field.
    Nature. 2025;648:S51-S53.
    PubMed    


  6. WILLYARD C
    Early detection could improve pancreatic cancer's poor survival rates.
    Nature. 2025;648:S54-S56.
    PubMed    


  7. HEDLEY E
    A breathalyser-style test for detecting pancreatic cancer.
    Nature. 2025;648:S57.
    PubMed    


  8. DATTARO L
    Pancreatic cancer is evasive. Is the nervous system the reason why?
    Nature. 2025;648:S49-S50.
    PubMed    


  9. VARGAS-PARADA L
    Six highlights from pancreatic cancer research.
    Nature. 2025;648:S61-S62.
    PubMed    


    November 2025

  10. Antibodies unleashed against pancreatic cancer.
    Nature. 2025;647:293.
    PubMed    


    October 2025
  11. STEMMLER MP
    Pancreatic cancer relies on opposing signalling pathways to drive its cellular diversity.
    Nature. 2025 Oct 22. doi: 10.1038/d41586-025-03133.
    PubMed    


  12. ZAKHAROV PN, Chowdhury CS, Peterson OJ, Barron B, et al
    Efferocytic remodelling of pancreatic islet macrophages by limited beta-cell death.
    Nature. 2025 Oct 1. doi: 10.1038/s41586-025-09560.
    PubMed     Abstract available


    September 2025
  13. LI H, Lan L, Chen H, Zaw Thin M, et al
    SPP1 is required for maintaining mesenchymal cell fate in pancreatic cancer.
    Nature. 2025 Sep 24. doi: 10.1038/s41586-025-09574.
    PubMed     Abstract available


    August 2025
  14. JEONG J, Hausmann S, Dong H, Szczepski K, et al
    NSD2 inhibitors rewire chromatin to treat lung and pancreatic cancers.
    Nature. 2025 Aug 6. doi: 10.1038/s41586-025-09299.
    PubMed     Abstract available


    June 2025
  15. SU H, Yang F, Fu R, Trinh B, et al
    Author Correction: Collagenolysis-dependent DDR1 signalling dictates pancreatic cancer outcome.
    Nature. 2025 Jun 18. doi: 10.1038/s41586-025-09285.
    PubMed    


    May 2025
  16. RADEMAKER G, Hernandez GA, Seo Y, Dahal S, et al
    PCSK9 drives sterol-dependent metastatic organ choice in pancreatic cancer.
    Nature. 2025 May 21. doi: 10.1038/s41586-025-09017.
    PubMed     Abstract available


  17. TINTELNOT J, Xu Y, Lesker TR, Schonlein M, et al
    Author Correction: Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer.
    Nature. 2025 May 13. doi: 10.1038/s41586-025-08979.
    PubMed    


    April 2025
  18. PEI G, Min J, Rajapakshe KI, Branchi V, et al
    Spatial mapping of transcriptomic plasticity in metastatic pancreatic cancer.
    Nature. 2025 Apr 23. doi: 10.1038/s41586-025-08927.
    PubMed     Abstract available


  19. CHENG C, Hu J, Mannan R, He T, et al
    Targeting PIKfyve-driven lipid metabolism in pancreatic cancer.
    Nature. 2025 Apr 23. doi: 10.1038/s41586-025-08917.
    PubMed     Abstract available


    February 2025
  20. SETHNA Z, Guasp P, Reiche C, Milighetti M, et al
    RNA neoantigen vaccines prime long-lived CD8(+) T cells in pancreatic cancer.
    Nature. 2025 Feb 19. doi: 10.1038/s41586-024-08508.
    PubMed     Abstract available



  21. Bespoke vaccines can elicit long-lived immune activity against pancreatic cancer.
    Nature. 2025 Feb 19. doi: 10.1038/d41586-025-00470.
    PubMed    


  22. THIEL V, Renders S, Panten J, Dross N, et al
    Characterization of single neurons reprogrammed by pancreatic cancer.
    Nature. 2025 Feb 17. doi: 10.1038/s41586-025-08735.
    PubMed     Abstract available


  23. SMITH J
    Daily briefing: A simple blood test could diagnose pancreatic cancer early.
    Nature. 2025 Feb 13. doi: 10.1038/d41586-025-00492.
    PubMed    


  24. MALLAPATY S
    Cheap blood test detects pancreatic cancer before it spreads.
    Nature. 2025 Feb 12. doi: 10.1038/d41586-025-00438.
    PubMed    


    January 2025
  25. AMISAKI M, Zebboudj A, Yano H, Zhang SL, et al
    IL-33-activated ILC2s induce tertiary lymphoid structures in pancreatic cancer.
    Nature. 2025 Jan 15. doi: 10.1038/s41586-024-08426.
    PubMed     Abstract available


    November 2024
  26. HUANG P, Gao W, Fu C, Wang M, et al
    Clinical functional proteomics of intercellular signalling in pancreatic cancer.
    Nature. 2024 Nov 13. doi: 10.1038/s41586-024-08225.
    PubMed     Abstract available


  27. WASKO UN, Jiang J, Dalton TC, Curiel-Garcia A, et al
    Author Correction: Tumour-selective activity of RAS-GTP inhibition in pancreatic cancer.
    Nature. 2024 Nov 12. doi: 10.1038/s41586-024-08084.
    PubMed    


    May 2024
  28. BRAXTON AM, Kiemen AL, Grahn MP, Forjaz A, et al
    3D genomic mapping reveals multifocality of human pancreatic precancers.
    Nature. 2024 May 1. doi: 10.1038/s41586-024-07359.
    PubMed     Abstract available


    April 2024
  29. WASKO UN, Jiang J, Dalton TC, Curiel-Garcia A, et al
    Tumor-selective activity of RAS-GTP inhibition in pancreatic cancer.
    Nature. 2024 Apr 8. doi: 10.1038/s41586-024-07379.
    PubMed     Abstract available


    November 2023
  30. CARONNI N, La Terza F, Vittoria FM, Barbiera G, et al
    IL-1beta(+) macrophages fuel pathogenic inflammation in pancreatic cancer.
    Nature. 2023 Nov 1. doi: 10.1038/s41586-023-06685.
    PubMed     Abstract available


    August 2023
  31. BEDNAR F, Pasca di Magliano M
    Calligraphy tool offers clues to the origin of pancreatic cancer.
    Nature. 2023 Aug 16. doi: 10.1038/d41586-023-02518.
    PubMed    


  32. FLETCHER AA, Kelly MS, Eckhoff AM, Allen PJ, et al
    Revisiting the intrinsic mycobiome in pancreatic cancer.
    Nature. 2023;620:E1-E6.
    PubMed    


  33. XU F, Saxena D, Pushalkar S, Miller G, et al
    Reply to: Revisiting the intrinsic mycobiome in pancreatic cancer.
    Nature. 2023;620:E7-E9.
    PubMed    


    May 2023
  34. NWOSU ZC, Ward MH, Sajjakulnukit P, Poudel P, et al
    Uridine-derived ribose fuels glucose-restricted pancreatic cancer.
    Nature. 2023 May 17. doi: 10.1038/s41586-023-06073.
    PubMed     Abstract available


  35. HUFF AL, Zaidi N
    Vaccine boosts T cells that target pancreatic tumours.
    Nature. 2023 May 10. doi: 10.1038/d41586-023-01526.
    PubMed    


  36. ROJAS LA, Sethna Z, Soares KC, Olcese C, et al
    Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer.
    Nature. 2023 May 10:1-7. doi: 10.1038/s41586-023-06063.
    PubMed     Abstract available


    March 2023
  37. LEE MS, Dennis C, Naqvi I, Dailey L, et al
    Ornithine aminotransferase supports polyamine synthesis in pancreatic cancer.
    Nature. 2023 Mar 29. doi: 10.1038/s41586-023-05891.
    PubMed     Abstract available


  38. PULESTON DJ
    A metabolic vulnerability of pancreatic cancer.
    Nature. 2023 Mar 29. doi: 10.1038/d41586-023-00848.
    PubMed    


  39. JBARA A, Lin KT, Stossel C, Siegfried Z, et al
    RBFOX2 modulates a metastatic signature of alternative splicing in pancreatic cancer.
    Nature. 2023 Mar 22. doi: 10.1038/s41586-023-05820.
    PubMed     Abstract available


  40. SU H, Yang F, Fu R, Trinh B, et al
    Publisher Correction: Collagenolysis-dependent DDR1 signalling dictates pancreatic cancer outcome.
    Nature. 2023 Mar 7. doi: 10.1038/s41586-023-05920.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Pancreatitis is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum